IMCY-0141 Safety and Efficacy in Multiple Sclerosis - ISEMIS Study
- Conditions
- Interventions
- First Posted Date
- 2022-06-14
- Last Posted Date
- 2024-03-08
- Lead Sponsor
- Imcyse SA
- Target Recruit Count
- 150
- Registration Number
- NCT05417269
- Locations
- 🇲🇩
Republican Clinical Hospital, ARENSIA Exploratory Medicine, Chisinau, Moldova, Republic of
In Vitro Study of the Biological and Immunological Activity of Imotopes® Candidates on Blood Cells of Patients With Stabilized NMO
- First Posted Date
- 2020-11-16
- Last Posted Date
- 2024-06-21
- Lead Sponsor
- Imcyse SA
- Target Recruit Count
- 15
- Registration Number
- NCT04629274
- Locations
- 🇫🇷
Hôpital Pierre Wertheimer, Bron, France
🇫🇷Hôpital de Hautepierre, Strasbourg, France
IMCY-0098 Proof of ACtion in Type 1 Diabetes (IMPACT Study)
- Conditions
- Interventions
- First Posted Date
- 2020-08-24
- Last Posted Date
- 2024-06-24
- Lead Sponsor
- Imcyse SA
- Target Recruit Count
- 110
- Registration Number
- NCT04524949
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
🇺🇸University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸Barbara Davis Center, Aurora, Colorado, United States
IMCY-T1D-002: Long-term Follow-up Study of T1D Patients Previously Treated With IMCY-0098 or Placebo
- First Posted Date
- 2019-12-09
- Last Posted Date
- 2022-05-02
- Lead Sponsor
- Imcyse SA
- Target Recruit Count
- 30
- Registration Number
- NCT04190693
- Locations
- 🇱🇹
Klaipeda University Hospital, KlaipÄ—da, Lithuania
🇸🇪ProbarE Stockholm, Stockholm, Sweden
🇬🇧Royal Devon and Exeter NHS Trust, Exeter, United Kingdom
Study of IMCY-0098 in Patients With Recent Onset Type 1 Diabetes
- First Posted Date
- 2017-09-05
- Last Posted Date
- 2019-09-06
- Lead Sponsor
- Imcyse SA
- Target Recruit Count
- 41
- Registration Number
- NCT03272269
- Locations
- 🇧🇪
Hôpital Erasme, Brussels, Belgium
🇫🇷CHU de Nantes, Hôpital Laennec, Nantes, France
🇸🇪ProbarE Stockholm, Stockholm, Sweden
A Trial for Evaluating Both Safety and Preliminary Efficacy of a Single Infusion of Stimulated Autologous CD4+T Cells in Patients With Relapsing- Remitting Multiple Sclerosis
- First Posted Date
- 2015-04-28
- Last Posted Date
- 2017-08-22
- Lead Sponsor
- Imcyse SA
- Target Recruit Count
- 2
- Registration Number
- NCT02427776
- Locations
- 🇧🇪
University Hospital Leuven (Gasthuisberg), Leuven, Belgium
🇧🇪University Hospital of Liège, Liège, Belgium
🇧🇪Cliniques universitaires Saint-Luc, Bruxelles, Belgium